Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering | Scientific Reports
![Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)](https://www.abcam.com/ps/products/51/ab51067/Images/ab51067-254008-anti-met-c-met-antibody-ep1454y-n-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)")
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents - ScienceDirect
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
c-Met Monoclonal Antibody (3D4) (18-7366)
Biomedicines | Free Full-Text | Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
![Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam](https://www.abcam.com/ps/products/216/ab216574/Images/ab216574-480637-antimet-cmet-antibody-ep1454y--nterminal-western-blot.JPG "Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam")
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
Anti-c-Met antibody
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
They Should Be in Jail': Nan Goldin, Anti-Sackler Opioid Activists Take Fight to Guggenheim, Met – ARTnews.com
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cancer Cell International | Full Text
Met (c Met) Polyclonal Antibody – Bioss
Met (c Met) Polyclonal Antibody – Bioss
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-290322-anti-met-c-met-antibody-sp44-c-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-4-AntiMet-cMet-antibody-SP44--Cterminal-IHC-Human-colon-carcinoma.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
